Supplementary Tables for 'Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use'
Published: 26 March 2020| Version 1 | DOI: 10.17632/n96f27nypz.1
Supplementary Table 1. Demographic Characteristics of 1039 Study Participants Supplementary Table 2. Common Cognitive Biases Affecting Adherence